
Apposite invests up to £12m in Medical Imaging Partnership
Healthcare-focused GP Apposite Capital has committed to invest up to £12m in Medical Imaging Partnership (MIP), a provider of radiology services.
Upon completion of the deal, MIP will look to make a number of new hires, including appointments to its senior management team. The company has recently opened a new office in Brighton to accommodate the team expansion.
MIP will also look to expand its services across the UK and invest in new product development.
Apposite partner Sam Gray will take a seat on the board of MIP as part of the deal.
In July 2015, Apposite sold Cancer Partners UK to GenesisCare, an Australian provider of radiotherapy services. It also recently appointed Nuage Labs’ CFO Anne-Laure Meynier as investment manager.
Company
Founded in 2010 and headquartered in Crawley, West Sussex, MIP provides radiology services to clients including the British National Health Service and various independent practitioners. It has a headcount of 55 and currently offers its services in the south-east and north of England.
MIP’s services include the distribution of radiology equipment, such as MRI, ultrasound and x-ray machinery. It also offers patient prioritisation advice and management, radiology reporting and clinical support.
People
Apposite – Sam Gray (partner).
MIP – Simon Oates (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater